Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis
Abstract When focal segmental glomerulosclerosis (FSGS) has reached the stage of chronic renal insufficiency, further progression is usually considered inevitable. African-American patients are believed to exhibit a particularly aggressive form of FSGS. We have treated five African-American patients, aged 11–18 years, with FSGS and reduced renal function using intensive intravenous methylprednisolone protocol, combined with chlorambucil in three cases. All patients had a pretreatment creatinine clearance of less than 50 ml/min per 1.73 $ m^{2} $. Three patients responded with normalization of creatinine clearance and serum albumin levels and had no or only minimal proteinuria at latest follow-up. One patient showed no improvement and one patient progressed to end-stage renal disease. These findings indicate, for the first time, that even severe FSGS may respond to aggressive methylprednisolone with or without alkylating agent treatment, and that African-American race does not preclude a favorable response..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1999 |
---|---|
Erschienen: |
1999 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Pediatric nephrology - 13(1999), 4 vom: Mai, Seite 298-300 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aviles, Diego H. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© IPNA - International Pediatric Nephrology Association New York, USA 1999 |
---|
doi: |
10.1007/s004670050612 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2056854708 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2056854708 | ||
003 | DE-627 | ||
005 | 20230502104727.0 | ||
007 | tu | ||
008 | 200820s1999 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s004670050612 |2 doi | |
035 | |a (DE-627)OLC2056854708 | ||
035 | |a (DE-He213)s004670050612-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Aviles, Diego H. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis |
264 | 1 | |c 1999 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © IPNA - International Pediatric Nephrology Association New York, USA 1999 | ||
520 | |a Abstract When focal segmental glomerulosclerosis (FSGS) has reached the stage of chronic renal insufficiency, further progression is usually considered inevitable. African-American patients are believed to exhibit a particularly aggressive form of FSGS. We have treated five African-American patients, aged 11–18 years, with FSGS and reduced renal function using intensive intravenous methylprednisolone protocol, combined with chlorambucil in three cases. All patients had a pretreatment creatinine clearance of less than 50 ml/min per 1.73 $ m^{2} $. Three patients responded with normalization of creatinine clearance and serum albumin levels and had no or only minimal proteinuria at latest follow-up. One patient showed no improvement and one patient progressed to end-stage renal disease. These findings indicate, for the first time, that even severe FSGS may respond to aggressive methylprednisolone with or without alkylating agent treatment, and that African-American race does not preclude a favorable response. | ||
700 | 1 | |a Irwin, Kimberly C. |4 aut | |
700 | 1 | |a Dublin, Linda S. |4 aut | |
700 | 1 | |a Vehaskari, V. Matti |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pediatric nephrology |d Springer-Verlag, 1987 |g 13(1999), 4 vom: Mai, Seite 298-300 |w (DE-627)130424285 |w (DE-600)631932-4 |w (DE-576)015925064 |x 0931-041X |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:1999 |g number:4 |g month:05 |g pages:298-300 |
856 | 4 | 1 | |u https://doi.org/10.1007/s004670050612 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2414 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4277 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4314 | ||
951 | |a AR | ||
952 | |d 13 |j 1999 |e 4 |c 05 |h 298-300 |